PloS one

Missing LDL receptor increases amyloid buildup and lowers immune cell activity in an Alzheimer's mouse model

Updated

Abstract

4-month-old 5XFAD transgenic mice lacking low-density lipoprotein receptors () show increased amyloid plaque deposition.

  • LDLR deficiency is associated with reduced astrocytosis and microgliosis in 5XFAD transgenic mice.
  • deletion decreases amyloid plaque formation but does not affect glial responses in 5XFAD mice.
  • 5XFAD mice lacking both ApoE and LDLR exhibit increased amyloid deposition along with decreased inflammatory responses.
  • Findings suggest that LDLR influences glial cell activity and amyloid plaque accumulation independently of ApoE.

Simplified

Key numbers

5 of 7
Increase in Amyloid Plaque Deposition
5XFAD/-/- mice showed increased Thioflavine-S positive amyloid deposits compared to 5XFAD mice.
5 of 7
Decrease in Glial Response
5XFAD/-/- mice displayed reduced astrocytic and microglial response compared to control.

Full Text

What this is

  • The study investigates the role of the () in Alzheimer's disease (AD) using a mouse model.
  • deficiency is shown to increase amyloid plaque deposition while decreasing astrocytic and microglial responses.
  • The findings suggest that regulates glial responses independently of (), a key factor in AD pathology.

Essence

  • deficiency increases amyloid plaque deposition in an AD mouse model while reducing the glial response, independent of levels.

Key takeaways

  • deficiency leads to increased amyloid plaque deposition in 5XFAD mice. This effect occurs regardless of presence, indicating 's role in amyloid pathology.
  • The absence of correlates with a significant decrease in astrocytic and microglial responses, suggesting that may modulate neuroinflammation in AD.

Caveats

  • The study focuses on a specific mouse model, which may limit the generalizability of the findings to human AD pathology.
  • Results are based on comparisons among genetically modified mice, which may introduce variability related to genetic background.

Definitions

  • Apolipoprotein E (ApoE): A cholesterol carrier protein that plays a significant role in lipid metabolism and is a major genetic risk factor for Alzheimer's disease.
  • Low-density lipoprotein receptor (LDLR): A receptor that regulates cholesterol levels in the body and is implicated in the pathology of Alzheimer's disease.

Simplified

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free